Physician_Profile_ID,Category,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID,Total_Amount_of_Payment_USDollars,Date_of_Payment,Category,Record_ID
68550,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,24.97,10/31/2013,GNRL,104454790
68550,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,19.65,11/26/2014,GNRL,148295916
68550,GNRL,"Actavis Pharma Inc",NJ,100000010642,19.57,01/08/2015,GNRL,339792206
68550,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,18.75,10/27/2014,GNRL,148400786
68550,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,18.68,11/27/2013,GNRL,100876404
68550,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,18.60,09/09/2014,GNRL,196323802
68550,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,18.46,08/13/2014,GNRL,199573006
68550,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,18.42,07/25/2014,GNRL,199573004
68550,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,18.05,12/03/2013,GNRL,104435664
68550,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,17.86,06/03/2014,GNRL,196323650
68550,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,16.93,10/02/2014,GNRL,148449772
68550,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,16.77,07/12/2014,GNRL,199573002
68550,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,16.74,10/21/2014,GNRL,196323798
68550,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,16.49,02/20/2014,GNRL,199572998
68550,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,16.36,09/11/2014,GNRL,149191422
68550,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,16.30,01/02/2014,GNRL,149884204
68550,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,16.30,05/27/2014,GNRL,150939528
68550,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,16.18,08/26/2014,GNRL,149793028
68550,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,16.13,09/23/2014,GNRL,156900440
68550,GNRL,"Lilly USA, LLC",IN,100000000066,15.99,01/05/2015,GNRL,268179874
68550,GNRL,"Novo Nordisk Inc",NJ,100000000144,15.96,01/27/2015,GNRL,266264578
68550,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,15.63,11/18/2014,GNRL,196323796
68550,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,15.63,10/09/2014,GNRL,196323800
68550,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,15.49,11/21/2013,GNRL,13974655
68550,GNRL,"Novo Nordisk Inc",NJ,100000000144,15.10,03/04/2014,GNRL,160960106
68550,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,15.04,06/24/2014,GNRL,199572994
68550,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,15.03,11/02/2013,GNRL,100859760
68550,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,15.00,08/15/2013,GNRL,103337202
68550,GNRL,"Novo Nordisk Inc",NJ,100000000144,14.97,10/07/2014,GNRL,162217142
68550,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,14.64,11/07/2013,GNRL,103337204
68550,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,14.59,06/12/2014,GNRL,196323648
68550,GNRL,"Amgen Inc.",CA,100000000203,14.54,11/05/2013,GNRL,8992065
68550,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,14.50,12/04/2014,GNRL,196323794
68550,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,14.50,12/18/2014,GNRL,194759956
68550,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,14.47,02/13/2014,GNRL,199572988
68550,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,14.07,09/16/2014,GNRL,199572986
68550,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,14.04,03/06/2014,GNRL,149887260
68550,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,13.88,07/10/2014,GNRL,196323646
68550,GNRL,"LILLY USA, LLC",IN,100000000066,13.75,08/14/2014,GNRL,137835526
68550,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,13.17,12/10/2014,GNRL,202580318
68550,GNRL,"Novo Nordisk Inc",NJ,100000000144,13.16,03/13/2014,GNRL,161114340
68550,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,13.14,08/21/2014,GNRL,196695580
68550,GNRL,"Pfizer Inc.",NY,100000000286,13.12,09/02/2014,GNRL,206762120
68550,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,13.00,09/24/2013,GNRL,100372526
68550,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,13.00,02/27/2014,GNRL,149134286
68550,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,12.89,05/01/2014,GNRL,194759944
68550,GNRL,"Lilly USA, LLC",IN,100000000066,12.83,01/20/2015,GNRL,268179872
68550,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,12.32,12/12/2014,GNRL,199572982
68550,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,12.32,01/21/2014,GNRL,196323654
68550,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,12.32,09/18/2014,GNRL,248161364
68550,GNRL,"Novo Nordisk Inc",NJ,100000000144,12.20,01/23/2014,GNRL,160899914
68550,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,12.10,11/12/2013,GNRL,100951222
68550,GNRL,"Pfizer Inc.",NY,100000000286,11.97,02/18/2014,GNRL,207050608
68550,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,11.91,10/03/2013,GNRL,14036704
68550,GNRL,"Pfizer Inc.",NY,100000000286,11.91,04/01/2014,GNRL,207360152
68550,GNRL,"Novo Nordisk Inc",NJ,100000000144,11.79,07/08/2014,GNRL,161572018
68550,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,11.79,04/17/2014,GNRL,197874030
68550,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,11.72,11/19/2013,GNRL,101167508
68550,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,11.72,10/16/2014,GNRL,149506348
68550,GNRL,"Novo Nordisk Inc",NJ,100000000144,11.72,10/14/2014,GNRL,162109536
68550,GNRL,"Novo Nordisk Inc",NJ,100000000144,11.60,08/25/2015,GNRL,266984376
68550,GNRL,"Novo Nordisk Inc",NJ,100000000144,11.43,12/23/2014,GNRL,162351248
68550,GNRL,"LILLY USA, LLC",IN,100000000066,11.41,08/21/2013,GNRL,4758027
68550,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,11.40,05/06/2014,GNRL,150667202
68550,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,11.30,11/06/2014,GNRL,197874026
68550,GNRL,"Novo Nordisk Inc",NJ,100000000144,11.23,10/02/2014,GNRL,162140610
68550,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,11.21,05/20/2014,GNRL,201745528
68550,GNRL,"Astellas Pharma US Inc",IL,100000000137,11.11,02/24/2014,GNRL,168897616
68550,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,11.05,12/17/2014,GNRL,148819482
68550,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,11.03,09/03/2013,GNRL,104335570
68550,GNRL,"LILLY USA, LLC",IN,100000000066,10.89,10/30/2014,GNRL,137873962
68550,GNRL,"Pfizer Inc.",NY,100000000286,10.88,10/28/2014,GNRL,207327930
68550,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,10.83,10/09/2013,GNRL,103337200
68550,GNRL,"Pfizer Inc.",NY,100000000286,10.83,10/17/2013,GNRL,205144604
68550,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,10.77,12/02/2014,GNRL,202541160
68550,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,10.74,04/15/2014,GNRL,196323652
68550,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,10.72,03/25/2014,GNRL,147258806
68550,GNRL,"Pfizer Inc.",NY,100000000286,10.71,12/05/2013,GNRL,205735118
68550,GNRL,"Pfizer Inc.",NY,100000000286,10.71,08/19/2014,GNRL,205896162
68550,GNRL,"Pfizer Inc.",NY,100000000286,10.71,09/09/2014,GNRL,206401348
68550,GNRL,"Bayer HealthCare LLC",NJ,100000005409,10.67,05/29/2014,GNRL,219055422
68550,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,10.65,07/01/2014,GNRL,197874028
68550,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,10.62,09/26/2014,GNRL,199572978
68550,GNRL,"LILLY USA, LLC",IN,100000000066,10.48,10/23/2013,GNRL,4721537
68550,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,10.44,09/12/2013,GNRL,23817232
68550,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,10.26,12/26/2013,GNRL,100372522
68550,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,10.15,12/19/2013,GNRL,100372524
68550,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,10.12,07/17/2014,GNRL,147258896
68550,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,10.11,02/04/2014,GNRL,147258858
68550,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,10.08,08/27/2013,GNRL,100904784
68550,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,9.82,03/20/2014,GNRL,147258852
68550,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,9.52,07/03/2014,GNRL,147258872
68550,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,9.23,08/13/2013,GNRL,104309084
68550,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,9.19,03/11/2014,GNRL,156900436
68550,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,8.43,07/15/2014,GNRL,147258890
68550,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,8.20,04/24/2014,GNRL,156900438
68550,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,7.94,05/06/2014,GNRL,150637478
68550,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,7.90,03/17/2014,GNRL,194759940
68550,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,7.71,08/28/2014,GNRL,147258864
68550,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,7.52,01/28/2014,GNRL,147258840
68550,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,7.33,01/16/2014,GNRL,147258828
68550,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,7.09,02/06/2014,GNRL,147258908
68550,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,6.91,06/10/2014,GNRL,147258884
68550,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,6.84,05/15/2014,GNRL,194759948
68550,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,5.70,02/25/2014,GNRL,147258926
68550,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,3.89,06/13/2014,GNRL,147258902
68550,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,3.82,01/23/2014,GNRL,147258846
68550,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,3.39,07/24/2014,GNRL,199572976
68550,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,2.08,08/07/2014,GNRL,147258920
68550,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,1.83,03/04/2014,GNRL,147258800
68550,GNRL,"Novo Nordisk Inc",NJ,100000000144,1.59,12/23/2014,GNRL,162351250
68550,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,0.99,05/15/2014,GNRL,147258914
68550,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,0.93,02/13/2014,GNRL,147258834
68550,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,0.88,04/17/2014,GNRL,147258823
68550,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,0.84,07/24/2014,GNRL,199572972
68550,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,0.83,02/20/2014,GNRL,199572968
68550,GNRL,"Novo Nordisk Inc",NJ,100000000144,0.74,10/14/2014,GNRL,162109540
68550,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,0.70,04/17/2014,GNRL,147258812
68550,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,0.68,02/12/2014,GNRL,199572961
68550,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,0.68,07/11/2014,GNRL,199572965
68550,GNRL,"Novo Nordisk Inc",NJ,100000000144,0.64,12/23/2014,GNRL,162351252
68550,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,0.60,08/12/2014,GNRL,199572958
68550,GNRL,"Novo Nordisk Inc",NJ,100000000144,0.56,03/04/2014,GNRL,160960110
68550,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,0.56,07/10/2014,GNRL,196695578
68550,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,0.52,09/16/2014,GNRL,199572954
68550,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,0.50,09/25/2014,GNRL,199572952
68550,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,0.49,03/20/2014,GNRL,147258818
68550,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,0.49,12/11/2014,GNRL,199572950
68550,GNRL,"Novo Nordisk Inc",NJ,100000000144,0.46,01/23/2014,GNRL,160899918
68550,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,0.45,12/17/2014,GNRL,194759952
68550,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,0.31,01/28/2014,GNRL,147258878
